Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-019237
Filing Date
2025-02-12
Accepted
2025-02-12 21:00:11
Documents
2
Period of Report
2025-02-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4071
2 EX-24 irwd-ex24.htm EX-24 11150
  Complete submission text file 0000950170-25-019237.txt   16670
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Issuer) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O IRONWOOD PHARMACEUTICALS, INC. 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
MCCOURT Thomas A (Reporting) CIK: 0001478448 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34620 | Film No.: 25616839